APA

Villa E., Cammà C., Di Leo A., Karampatou A., Enea M., Gitto S., Bernabucci V., Losi L., De Maria N., Lei B., Ferrari A., Vukotic R., Vignoli P., Rendina M. & Francavilla A. (20121207). Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. : Journal of viral hepatitis.

Chicago

Villa E, Cammà C, Di Leo A, Karampatou A, Enea M, Gitto S, Bernabucci V, Losi L, De Maria N, Lei B, Ferrari A, Vukotic R, Vignoli P, Rendina M and Francavilla A. 20121207. Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. : Journal of viral hepatitis.

Harvard

Villa E., Cammà C., Di Leo A., Karampatou A., Enea M., Gitto S., Bernabucci V., Losi L., De Maria N., Lei B., Ferrari A., Vukotic R., Vignoli P., Rendina M. and Francavilla A. (20121207). Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. : Journal of viral hepatitis.

MLA

Villa E, Cammà C, Di Leo A, Karampatou A, Enea M, Gitto S, Bernabucci V, Losi L, De Maria N, Lei B, Ferrari A, Vukotic R, Vignoli P, Rendina M and Francavilla A. Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. : Journal of viral hepatitis. 20121207.